Overview

Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) Patients

Status:
COMPLETED
Trial end date:
2002-02-01
Target enrollment:
Participant gender:
Summary
The Objective of this study is to assess the Safety and Tolerability of 200 mg and 100 mg of Venofer Administered to Hemodialysis(HD) Patients.
Phase:
PHASE4
Details
Lead Sponsor:
American Regent, Inc.
Treatments:
Ferric Oxide, Saccharated